MLiss A Hudson
Overview
Explore the profile of MLiss A Hudson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catalona W, Richie J, Ahmann F, Hudson M, Scardino P, Flanigan R, et al.
J Urol
. 2016 Dec;
197(2S):S200-S207.
PMID: 28012755
To compare the efficacy of digital rectal examination and serum prostate specific antigen (PSA) in the early detection of prostate cancer, we conducted a prospective clinical trial at 6 university...
2.
Schmitz-Drager B, Kuckuck E, Zuiverloon T, Zwarthoff E, Saltzman A, Srivastava A, et al.
Urol Oncol
. 2016 Sep;
34(10):437-51.
PMID: 27641313
Rationale: Assessment of patients with asymptomatic microhematuria (aMh) has been a challenge to urologists for decades. The aMh is a condition with a high prevalence in the general population and...
3.
Saltzman A, Luo S, Scherrer J, Carson K, Grubb 3rd R, Hudson M
Urol Oncol
. 2015 May;
33(7):330.e9-17.
PMID: 25937424
Background: To determine whether prostate-specific antigen (PSA) testing in African American veterans (AAVs) aged 40 to 54 years is associated with high-risk prostate cancer characteristics compared with AAVs aged 55...
4.
Schmitz-Drager B, Droller M, Lokeshwar V, Lotan Y, Hudson M, van Rhijn B, et al.
Urol Int
. 2014 Dec;
94(1):1-24.
PMID: 25501325
Due to the lack of disease-specific symptoms, diagnosis and follow-up of bladder cancer has remained a challenge to the urologic community. Cystoscopy, commonly accepted as a gold standard for the...
5.
Goebell P, Kamat A, Sylvester R, Black P, Droller M, Godoy G, et al.
Urol Oncol
. 2014 Aug;
32(7):1051-60.
PMID: 25159014
Objectives: With rapidly increasing numbers of publications, assessments of study quality, reporting quality, and classification of studies according to their level of evidence or developmental stage have become key issues...
6.
Schmitz-Drager B, Todenhofer T, Van Rhijn B, Pesch B, Hudson M, Chandra A, et al.
Urol Oncol
. 2014 Jan;
32(7):1061-8.
PMID: 24411790
Objectives: Many molecular assays for bladder cancer diagnosis and surveillance have been developed over the past several decades. However, none of these markers have been routinely implemented into clinical decision...
7.
Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson M, Luo S, Chrusciel T, Yan Y, Grubb 3rd R, Carson K, et al.
Urol Oncol
. 2013 Mar;
32(1):34.e9-18.
PMID: 23506962
Objective: To determine whether racial disparities exist in the use of prostate cancer screening and detection tools in veterans. Methods And Materials: Administrative data were obtained from the Corporate Data...
8.
9.
Skolarus T, Lee E, Virgo K, Katz M, Hudson M, Kibel A, et al.
J Am Coll Surg
. 2009 Jul;
209(2):248-53.
PMID: 19632602
Background: Recent studies provide conflicting evidence about the association of statin use and decreased efficacy of intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer. Because statin drugs have immunomodulatory properties...
10.
Catalona W, Hudson M, Scardino P, Richie J, Ahmann F, Flanigan R, et al.
J Urol
. 1994 Dec;
152(6 Pt 1):2037-42.
PMID: 7525995
A prospective clinical trial of prostate cancer screening was conducted at 6 university centers including 6,630 men 50 years old or older who underwent a serum prostate specific antigen (PSA)...